Literature DB >> 23145526

Eosinophilic pulmonary granulomatosis in a young dog with prolonged remission after treatment.

P Katajavuori1, M Melamies, M M Rajamäki.   

Abstract

A two-year-old Jack Russell terrier was presented for evaluation of chronic cough and exercise intolerance. Previous treatment with antibiotics and glucocorticoids had only partially ameliorated the clinical signs. During investigation, hypoxaemia, peripheral eosinophilia and an eosinophilic bronchoalveolar lavage fluid were noted. Thoracic radiographs revealed two ovoid clearly delineated soft-tissue opacities, one in the caudal segment of the left cranial lung lobe (diameter 26 mm) and the other in the right cranial lung lobe (diameter 20 mm). These findings were verified by computed tomography, which identified an additional smaller lesion (diameter 16 mm) dorsally in the right caudal lobe. Ultrasound-guided fine-needle aspiration samples confirmed the diagnosis of eosinophilic pulmonary granulomatosis and treatment with prednisolone and azathioprine was initiated. Within 1 month, granulomas were no longer detectable radiographically. All medication was discontinued after 7 months and currently, after 2·5 years, the dog remains free of clinical signs. To the authors' knowledge this is the first case report to describe prolonged remission from idiopathic canine eosinophilic pulmonary granulomatosis.
© 2012 British Small Animal Veterinary Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23145526     DOI: 10.1111/j.1748-5827.2012.01308.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  2 in total

Review 1.  Canine eosinophilic pulmonary granulomatosis: case report and literature review.

Authors:  Dawn E E Abbott; Andrew L Allen
Journal:  J Vet Diagn Invest       Date:  2020-03       Impact factor: 1.279

2.  Eosinophilic bronchitis, eosinophilic granuloma, and eosinophilic bronchopneumopathy in 75 dogs (2006-2016).

Authors:  Lynelle R Johnson; Eric G Johnson; Sean E Hulsebosch; Jonathan D Dear; William Vernau
Journal:  J Vet Intern Med       Date:  2019-08-29       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.